10;25(Suppl 1):35-41.
475. Katsenis K. Micronized puriﬁed ﬂavonoid fraction (MPFF): A review
of its pharmacological effects, therapeutic efﬁcacy and beneﬁts in the
management of chronic venous insufﬁciency. Curr Vasc Pharmacol
2005;3:1-9.
476. Coleridge Smith PD. From skin disorders to venous leg ulcers:
Pathophysiology and efﬁcacy of Daﬂon 500 mg in ulcer healing.
Angiology 2003;54(Suppl 1):S45-50.
477. Jull A, Arroll B, Parag V, Waters J. Pentoxifylline for treating venous
leg ulcers. Cochrane Database Syst Rev 2007;3:CD001733.
478. Jull A, Waters J, Arroll B. Pentoxifylline for treatment of venous leg
ulcers: A systematic review. Lancet 2002;359:1550-4.
479. De Sanctis MT, Belcaro G, Cesarone MR, Ippolito E, Nicolaides AN,
Incandela L, et al. Treatment of venous ulcers with pentoxifylline: A
12-month, double-blind, placebo controlled trial. Microcirculation
and healing. Angiology 2002;53(Suppl 1):S49-51.
480. Falanga V, Fujitani RM, Diaz C, Hunter G, Jorizzo J, Lawrence PF,
et al. Systemic treatment of venous leg ulcers with high doses of
pentoxifylline: Efﬁcacy in a randomized, placebo-controlled trial.
Wound Repair Regen 1999;7:208-13.
481. Dale JJ, Ruckley CV, Harper DR, Gibson B, Nelson EA, Prescott RJ.
Randomised, double blind placebo controlled trial of pentoxifylline in
the treatment of venous leg ulcers. BMJ 1999;3